Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
about
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeDuctal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomesIVF and breast cancer: a systematic review and meta-analysisDietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohortDeciphering the divergent roles of progestogens in breast cancer.Ductal carcinoma in situ of the breast: a surgical perspective.Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysisHeterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Towards research-tested smartphone applications for preventing breast cancerDevelopment of the Physical activity and Your Nutrition for Cancer (PYNC) smartphone app for preventing breast cancer in womenHistological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of ageExpression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationUse of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.Socioeconomic disparities in the decline in invasive breast cancer incidence.The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysisSpecialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.Perimenopausal risk factors and future health.Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure[The place of magnetic resonance imaging in lobular carcinoma of the breast].Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer.Relationship between menopausal symptoms and risk of postmenopausal breast cancer.Risk factors for ductal and lobular breast cancer: results from the nurses' health study.Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study.Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.Hormonal therapy and risk of breast cancer in mexican women.Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers StudyInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.Genetic predisposition to in situ and invasive lobular carcinoma of the breast.Lobular breast cancer: incidence and genetic and non-genetic risk factors.Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative StudyPostmenopausal hormone therapy and breast cancer risk: current status and unanswered questions.Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort.
P2860
Q21195226-BF79A682-852D-4C0A-B1BD-01C09546EB3CQ28270358-348FD61A-CFD9-4B6D-A974-09AB1F6D5E2CQ28295207-C448B434-D3E5-445D-9841-EFE2A5B5C545Q28394566-332D8137-4C8E-44A6-946E-28070C62ADE7Q30240711-53DC072F-D8A3-4FEB-A101-68712E664B09Q30463534-611478E6-E9C3-4351-A6E2-A076B3EF1B5CQ30879035-D50ECD6C-BCB8-41D4-9012-15A1AE1B70DFQ33330850-A2FD399C-51C1-4152-893F-127B58E298B6Q33449572-0CCBEF89-C661-4599-8D6E-1813EBB58F2CQ33453417-4BD406CA-02A8-4C57-B9AD-F4950F3CEA36Q33584230-80E35863-D64E-4A34-98CF-6DFC78B7AD63Q33644735-66197EC9-4112-4402-A326-8C21AA640916Q33781177-35FD24A6-CEF3-4C8C-8BD7-94E5533A8F6CQ33823771-32CF440E-5C80-42BF-9C69-DEC5ED3E4DAAQ33898676-D1982202-2F36-4ABD-9E5A-074A5CAB1C5BQ33903091-1E1D935B-664D-42D7-BC02-D44415B1645FQ33957253-6F15A5DA-7E57-4F9F-A8FA-932E1C0A5CC4Q33996491-A898D5A8-CFAC-4631-A9DF-87C0114F5B9EQ33998106-798AADA3-102E-4308-98AB-4FE74F6D2453Q34003218-6E189C30-C7F8-42A2-BFCE-7DB5F52BB448Q34115930-86D3ADFF-C404-4B33-AA65-C0229931F247Q34132812-8E918D15-5356-46C6-9DDD-0310E7F53CE0Q34184608-B9E71502-C07F-4785-9ED9-1558AD7D138FQ34281974-CCD6157D-38B9-4964-90E8-3AC6E00D070DQ34427840-FD14AFAF-9AB6-4135-8284-9C2612F2706AQ34488648-5444B907-59EC-449D-AE47-5DE01904D23DQ34555256-1E12EC4A-B16F-4A2A-ABAD-1256D437CB41Q34568764-28EB1719-01C0-457E-8849-A1148DC0A416Q34613642-41FAA792-F4EA-4677-A179-D8848A28FF91Q35017932-2B8F2227-E228-4139-9C97-14E6580C31FCQ35040736-594B82EB-0A09-4D3C-939B-0B6791FD91F3Q35048651-3091D3C7-9CBD-4FDB-ABF5-43E5855B64CEQ35052877-48A84DAB-B637-4474-8CFB-C2C3714D6146Q35086250-D97C8D0C-5CE7-4C5E-BAD9-82E501306700Q35151684-00CB704A-E30B-49B9-9AEF-E24935958F0FQ35170028-58DD9A5C-F36E-4CB8-9217-8464EE5AA003Q35188724-C810DBB0-82B8-4EB6-92EA-9B73609FE9DEQ35196707-118896B7-0C05-461B-9C29-859ADD9C9141Q35421375-4F8B24DF-B73C-4749-8F97-68653B0D63EFQ35733402-A0FF1967-3445-4B63-8BB3-B4E4BF7CA30B
P2860
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@ast
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@en
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@nl
type
label
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@ast
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@en
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@nl
prefLabel
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@ast
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@en
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@nl
P50
P1433
P1476
Hormonal therapy for menopause ...... ohort study and meta-analysis.
@en
P2093
Diana Bull
Jane Green
P304
P356
10.1016/S1470-2045(06)70911-1
P577
2006-11-01T00:00:00Z